September 15 -18, 2025
Hynes Convention CenterBoston, USAKey Sessions
Niklas Engler
PLENARY KEYNOTE: CMC Development - A Key Differentiator for Biotech
F. Hoffmann-La Roche
James Warren
PLENARY KEYNOTE: Case Study from Ultragenyx On CMC Development for New Products
Ultragenyx
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL